[PDF] Top 20 Legitimación activa en la acción de colación
Has 6797 "Legitimación activa en la acción de colación" found on our website. Below are the top 20 most common "Legitimación activa en la acción de colación".
An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease
... from inhaled corticosteroid long-acting beta-agonist combination inhalers on the frequency of exacerba- tions, (rate ratio [RR], ...the inhaled corticosteroids currently available (fluticasone and ... See full document
6
Effects of inhaled corticosteroids on airway inflammation in chronic obstructive pulmonary disease: a systematic review and meta-analysis
... Propagate, Pulmonary Reviews, Pulmatrix, Reckner Associates, Recruiting Resource, Roche, Sankyo, Schering, Schlesinger Medical, Scimed, Smith Research, Sudler and Hennessey, Summer Street Research, Talecris, Think ... See full document
6
Elevated placenta growth factor predicts pneumonia in patients with chronic obstructive pulmonary disease under inhaled corticosteroids therapy
... According to the GOLD guidelines and clinical practice, ICS were prescribed for patients with severe and, very severe obstructive lung defects or frequent acute exacerba- tion (125 (45.6%) ICS users). Pneumonia ... See full document
14
Switching treatments in COPD: implications for costs and treatment adherence
... Abstract: Inhaled therapy is key to the management of chronic obstructive pulmonary disease ...used inhaled bronchodilators and corticosteroids will be accompanied by the ... See full document
14
Effects of inhaled corticosteroids on sputum cell counts in stable chronic obstructive pulmonary disease: a systematic review and a meta-analysis
... have shown that eosinophils are exquisitely sensitive to corticosteroids [29,30]. The current data, however, suggest otherwise. Several studies have demonstrated that among COPD patients with irreversible airflow ... See full document
9
Inhaled corticosteroids might not increase the risk of pneumonia in patients with chronic obstructive pulmonary disease in Japan
... sible explanation for the difference in findings between our study and the TORCH study is that the dose of ICS was smaller in our study than in the TORCH study. We could not demonstrate significance concerning the dose ... See full document
26
Chronic obstructive pulmonary disease treated with inhaled medium- or high-dose corticosteroids: a prospective and randomized study focusing on clinical efficacy and the risk of pneumonia
... This study was initiated in June 2010. A total of 237 patients were randomized into the two treatment arms (115 patients in the HD group, and 122 in the MD group), of whom 217 (91.6%) completed the study and 20 (8.4%) ... See full document
18
Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease
... emergency department, patients presenting with an AECOPD were randomized to receive either oral prednisone once daily for 10 days (n = 74) or matching placebo (n = 73). After being counseled on proper inhaler technique, ... See full document
9
Airway remodelling in smokers with or without chronic obstructive pulmonary disease (COPD) and the effects of inhaled corticosteroids on remodelling in COPD
... for Obstructive Lung Disease (GOLD) COPD is a preventable and treatable disease characterized by airflow limitation that is not fully ...with inhaled corticosteroids (ICS) and/or long- ... See full document
212
Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?
... vs Inhaled Corticosteroid Plus Long-acting β 2 -Agonist Therapy for Chronic Obstructive Pulmonary Disease (TRILOGY) study of COPD patients with severe or very severe airflow limitation ... See full document
6
The dose of inhaled corticosteroids in patients with COPD: when less is better
... Once-daily inhaled fluti- casone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled ...severe chronic ... See full document
16
Toward effective prescription of inhaled corticosteroids in chronic airway disease
... of Chronic Obstructive Pulmonary Disease ‘Editorial’ section does not necessarily represent the views of Dove Medical Press, its officers, agents, employees, related entities or the ... See full document
5
Airway epithelial platelet-activating factor receptor expression is markedly upregulated in chronic obstructive pulmonary disease
... to chronic obstructive pulmonary disease ...of inhaled corticosteroids (ICS) in COPD patients is associated with an increased risk of invasive respira- tory pneumococcal ... See full document
10
The disease burden of chronic obstructive pulmonary disease in Greece
... comorbidities, disease history, perceived disease severity, breathless- ness severity, symptoms severity, limitations in daily activities, psychological distress, and productivity were ... See full document
5
Altered deposition of inhaled nanoparticles in subjects with chronic obstructive pulmonary disease
... respiratory disease. Respiratory disease was assessed with pulmonary function testing and, for subjects with previously diagnosed disease, computed tomography ...respiratory disease ... See full document
23
Chronic obstructive lung disease and posttraumatic stress disorder: current perspectives
... This structured review began with an initial literature search performed by a health sciences librarian (AB) using several indexed databases: MEDLINE through Ovid, Cochrane Database of Systematic Reviews through Wiley, ... See full document
30
Outpatient pulmonary rehabilitation – rehabilitation models and shortcomings in outpatient aftercare
... Asthma is a chronic inflammation of the respiratory sys- tem. In the treatment of asthma priority is given to the avoidance of symptoms and the interference of activities. Especially for COPD, positive effects of ... See full document
507
The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients’ life quality with COPD in Taiwan (IMPACT) study
... The results of the present study should be interpreted in light of its both strength and weakness. One of the major strengths is that this investigation was a nationwide population-based cross-sectional study that ... See full document
16
<p>Status of and strategies for improving adherence to COPD treatment</p>
... The presence of speci fi c comorbidities may also be rele- vant not only because of the effect on the number of medications but also because of the impact of these comor- bidities on COPD. The best example is the ... See full document
5
Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF α antagonists
... [44]. Disease duration is generally considered a risk factor for infections [19,45], whereas in this study, surprisingly, it was ...but disease duration is very likely to be confounded with other factors, ... See full document
5
Related subjects